Perkins Represented in Premiers Science Awards
By Richard Schoonraad | Antibiotic diagnostics, awards, BioDiscovery, Community, Epigenetics and Genomics Laboratory, Genetic Disease, Genetic Disease, Lungs, Media Releases, News & Events, ResearchThree celebrated scientists from WA’s Harry Perkins Institute of Medical Research, have been named as finalists in the 2024 Premier’s Science Awards. Associate Professor Gina Ravenscroft, Dr Kieran Mulroney and…
‘Smart’ Plants for Space Travel
By Richard Schoonraad | Epigenetics and Genomics Laboratory, Genome Biology and Genetic Diseases, Media Releases, News & Events, ResearchResearchers from Harry Perkins Institute of Medical Research and the University of Western Australia have developed synthetic genetic circuits that can turn plant genes on or off based on the…
Perkins pioneering research gets funding boost
By Richard Schoonraad | Funding, Media Releases, News & Events, ResearchPerth’s Harry Perkins Institute of Medical Research is set to boost its life-changing research outcomes, thanks to generous funding from the Future Health Research and Innovation (FHRI) Fund Enabling Scheme.…
Perkins researchers granted funds to advance epigenetic research
By Richard Schoonraad | Epigenetics and Genomics Laboratory, Funding, Genome Biology and Genetic Diseases, Lab, Media Releases, News & Events, ResearchTwo researchers at the Harry Perkins Institute of Medical Research have been awarded separate grants totalling $3.6million in federal government funding to better understand and treat diseases. Perkins CEO, Prof…
“Google map” of ovarian tumours reveals cancer cells control who gets into their neighbourhood
By Richard Schoonraad | Cancer, Cancer, Cancer and Cell Biology, Genetic Disease, Genetic Disease, Genome Biology and Genetic Diseases, Lab, News & Events, Ovarian Cancer, Research, TumoursPerth researchers find some ovarian cancer cells appear to tell immune system to stay away. “Spatial transcriptomics reveals discrete tumour microenvironments and autocrine loops within ovarian cancer subclones” published in…
Phase 3 drug trial for rare chronic kidney disease achieves key milestone
By Richard Schoonraad | Chronic Kidney Disease, Kidney Disease, Lab, Media Releases, Molecular Endocrinology and Pharmacology, News & Events, Research, Research AreaBiopharmaceutical company, Dimerix Limited (ASX: DXB, “Dimerix”), which is developing new treatments for types of inflammatory kidney and respiratory diseases, has announced successful interim results of a Phase 3 trial…
Support needed for doctors offering couples genetic testing
By Richard Schoonraad | Epigenetics and Genomics Laboratory, Genetic Disease, Media Releases, Muscles, News & Events, Rare Disease Genetics and Functional Genomics, ResearchAs the number of genetic abnormalities that can be identified in pre and post pregnancy tests reaches the thousands, a national project has been launched to assist doctors as they…
Predicting immunotherapy effectiveness in late-stage liver cancer
By Richard Schoonraad | Cancer, Cancer, Funding, Immunotherapy, Liver, Liver Cancer, Liver Cancer, Liver Disease, Liver Disease, News & Events, ResearchBlood test could hold key to identifying who will respond to immunotherapy after researchers discover biomarkers in liver cancer tissue. Liver cancer researchers at the Harry Perkins Institute of Medical…